77 related articles for article (PubMed ID: 31209722)
1. Correction to: A1CF-Axin2 signal axis regulates apoptosis and migration in Wilms tumor-derived cells through Wnt/β-catenin pathway.
Ni D; Liu J; Hu Y; Liu Y; Gu Y; Zhou Q; Xie Y
In Vitro Cell Dev Biol Anim; 2019 Oct; 55(9):776. PubMed ID: 31209722
[TBL] [Abstract][Full Text] [Related]
2. A1CF-Axin2 signal axis regulates apoptosis and migration in Wilms tumor-derived cells through Wnt/β-catenin pathway.
Ni D; Liu J; Hu Y; Liu Y; Gu Y; Zhou Q; Xie Y
In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):252-259. PubMed ID: 30825095
[TBL] [Abstract][Full Text] [Related]
3. Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation.
Schweigert A; Fischer C; Mayr D; von Schweinitz D; Kappler R; Hubertus J
Pediatr Surg Int; 2016 Dec; 32(12):1141-1146. PubMed ID: 27679509
[TBL] [Abstract][Full Text] [Related]
4. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Wilms' tumor gene 1 (WT1) in desmoid tumors.
Amini Nik S; Hohenstein P; Jadidizadeh A; Van Dam K; Bastidas A; Berry RL; Patek CE; Van der Schueren B; Cassiman JJ; Tejpar S
Int J Cancer; 2005 Mar; 114(2):202-8. PubMed ID: 15540161
[TBL] [Abstract][Full Text] [Related]
6. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE
Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125
[TBL] [Abstract][Full Text] [Related]
7. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
[TBL] [Abstract][Full Text] [Related]
8. Apobec-1 complementation factor regulates cell migration and apoptosis through Dickkopf1 by acting on its 3' untranslated region in MCF7 cells.
Yan X; Li Q; Ni D; Xie Y; He Q; Wan Q; Liu Y; Lyu Z; Mao Z; Zhou Q
Tumour Biol; 2017 Jun; 39(6):1010428317706218. PubMed ID: 28639893
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin expression and mutation in adult and pediatric Wilms' tumors.
Su MC; Huang WC; Lien HC
APMIS; 2008 Sep; 116(9):771-8. PubMed ID: 19024596
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
11. Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms.
Li Y; Wang J; Li X; Jia Y; Huai L; He K; Yu P; Wang M; Xing H; Rao Q; Tian Z; Tang K; Wang J; Mi Y
Oncol Rep; 2014 Dec; 32(6):2680-6. PubMed ID: 25310451
[TBL] [Abstract][Full Text] [Related]
12. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.
Li CM; Kim CE; Margolin AA; Guo M; Zhu J; Mason JM; Hensle TW; Murty VV; Grundy PE; Fearon ER; D'Agati V; Licht JD; Tycko B
Am J Pathol; 2004 Dec; 165(6):1943-53. PubMed ID: 15579438
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors.
Yan D; Wiesmann M; Rohan M; Chan V; Jefferson AB; Guo L; Sakamoto D; Caothien RH; Fuller JH; Reinhard C; Garcia PD; Randazzo FM; Escobedo J; Fantl WJ; Williams LT
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14973-8. PubMed ID: 11752446
[TBL] [Abstract][Full Text] [Related]
14. SOX7 co-regulates Wnt/β-catenin signaling with Axin-2: both expressed at low levels in breast cancer.
Liu H; Mastriani E; Yan ZQ; Yin SY; Zeng Z; Wang H; Li QH; Liu HY; Wang X; Bao HX; Zhou YJ; Kou JJ; Li D; Li T; Liu J; Liu Y; Yin L; Qiu L; Gong L; Liu SL
Sci Rep; 2016 May; 6():26136. PubMed ID: 27188720
[TBL] [Abstract][Full Text] [Related]
15. Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors.
Koesters R; Ridder R; Kopp-Schneider A; Betts D; Adams V; Niggli F; Briner J; von Knebel Doeberitz M
Cancer Res; 1999 Aug; 59(16):3880-2. PubMed ID: 10463574
[TBL] [Abstract][Full Text] [Related]
16. Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.
Major MB; Camp ND; Berndt JD; Yi X; Goldenberg SJ; Hubbert C; Biechele TL; Gingras AC; Zheng N; Maccoss MJ; Angers S; Moon RT
Science; 2007 May; 316(5827):1043-6. PubMed ID: 17510365
[TBL] [Abstract][Full Text] [Related]
17. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
[TBL] [Abstract][Full Text] [Related]
18. Derivation and characterization of a Wilms' tumour cell line, WiT 49.
Alami J; Williams BR; Yeger H
Int J Cancer; 2003 Nov; 107(3):365-74. PubMed ID: 14506735
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of a novel missense mutation in AXIN2 associated with non-syndromic tooth agenesis.
Yue H; Liang J; Yang K; Hua B; Bian Z
Eur J Oral Sci; 2016 Jun; 124(3):228-33. PubMed ID: 27090353
[TBL] [Abstract][Full Text] [Related]
20. Coordinated action of Axin1 and Axin2 suppresses β-catenin to regulate muscle stem cell function.
Figeac N; Zammit PS
Cell Signal; 2015 Aug; 27(8):1652-65. PubMed ID: 25866367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
